Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by Sniper007on Dec 11, 2013 11:29pm
276 Views
Post# 21997296

RE:Shuttling on...

RE:Shuttling on...For those of you who missed jdstox post re: Roche's Brain Shuttle

jdstox wrote:

The Roche "Brain Shuttle" method of crossing the BBB has been mentioned for a couple of years on this forum. It uses a different transferrin protein that biOasis uses. It is capable of transferring about 1 to 1½ per cent of an injected (I mean, infused, ahem...) dose across the BBB compared to 4 to 6 percent (and higher) by biOasis's Transcend.

.

But there are some quotes about the Roche Shuttle method in an article (found here) that are interesting and informative. You can see the value of the Roche Brain Shuttle. Imagine the value of Transcend that can use far smaller doses to achieve the same results as the Roche Shuttle or that can introduce far greater doses where needed.

.

I have some things to say about biOasis and the current share price. My comments might be a little (or very) critical of biOasis but, as always, it ain't what we say, it's what we do that counts. I'm holding biOais, fully, completely, confidently. I'll try to write my comments today and get them on my blog later today or tomorrow.

.

I'm not too interested in holding hands with worried investors through this dip. I'm very much at peace with biOasis. It's been documented that 3 large molecule cancer drugs (paclitaxel, adriamycin and Herceptin) have been transported across the BBB with p97 (melanotransferrin) and/or Transcend. Three for three is pretty convincing, don't you think?

.

jdstox

.



Bullboard Posts